Antibody and CD8+ T Cell Responses: How the Delta Variant Evades Immunity?

SARS-CoV-2 vaccines have reduced efficiency against variants of concern. Find out how antibody and T cell responses are affected by variant associated mutations.

Targeting Multiple Conserved T-Cell Epitopes for Protection against COVID-19 Moderate-Severe Disease by a Pan-Sarbecovirus Vaccine

Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity, Inflammation and Regeneration

Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines - Sette - 2022 - Immunological Reviews - Wiley Online Library

Vaccine-elicited B- and T-cell immunity to SARS-CoV-2 is impaired in chronic lung disease patients

Evaluation of SARS-CoV-2-Specific T-Cell Activation with a Rapid On-Chip IGRA

Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope - ScienceDirect

T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study - The Lancet Microbe

Frontiers CD8+ T-cell immune escape by SARS-CoV-2 variants of concern

Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine